U.S. pharma large copyright scrapped two experimental weight loss products final yr—a the moment-every day capsule, lotiglipron, as a result of elevated liver enzymes and also a two times-everyday pill, danuglipron, as a consequence of potent Uncomfortable side effects—but CEO Albert